SYNJ2 and early-onset autosomal dominant Alzheimer disease: Synaptojanin 2 (SYNJ2) was reported as a cell-type-specific methylation biomarker associated with aging, especially in neuronal diseases, such as Alzheimer's disease (44) and progressive hearing loss (45).